Health care is considered a high stakes issue in the 2020 presidential election in terms of both health insurance coverage and affordability of care. In Part 2 of Sg2 Perspectives' 2-part election series, Vizient Senior Government Relations and Policy Director Steve Rixen once again joins Sg2’s Bill Woodson and Valinda Rutledge to discuss the potential fate of the Affordable Care Act as well as the path forward for value-based care.

All day, every day we are flooded with 2020 presidential election coverage, but rarely do we get a nuanced analysis of how a new or continued administration will impact policies most important to health systems. In Part 1 of Sg2 Perspective’s 2-part election series, we discuss one such policy as Vizient Senior Government Relations and Policy Director Steve Rixen joins Sg2’s Bill Woodson and Valinda Rutledge to discuss how a Trump administration or a Biden administration would likely address high drug costs and what that means for health system providers.

Sg2’s Principal Tawnya Bosko, DHA, and Senior Director Justin Cassidy, PhD, share insights on what the last six months of the pandemic looked like for academic medical centers, and how those challenges and adaptations are contributing to the evolution of their historic role from destinations for care to destinations of expertise.

Sg2 members can dive deeper with our AMC Resource Kit.

Contact the Sg2 team at [email protected]

As Providence St. Joseph Health System’s James Harker, Chief Population Health Officer, said, “…value-based care, though,” calling out that even though 2020 hasn’t been smooth, value-based arrangements are helping health care organizations. This week, we continue our focus on value-based care with him, discussing the opportunity for business model disruption in Medicare, Medicaid, and commercial payer segments and highlighting winning strategies for achieving success.

Please share your feedback about this episode, or other comments with Trevor and Kelly at [email protected]

We all know it: 2020 has been a rough year so far. But as this week’s guest, Providence St. Joseph Health System’s James Harker, Chief Population Health Officer, said “…value-based care, though.” What he means: payment news in health care isn’t all bad, and those with value-based care arrangements are faring a bit better. In this episode, we discuss how value-based care models serve as a stable business model through a tumultuous time and have the ability to better align incentives and increase shared accountability between payers, providers and patients.

Please share your feedback about this episode, or other comments with Trevor and Kelly at [email protected]

News is changing fast about the rapid progress being made to develop a COVID-19 vaccine.  Sg2 Principals Henry Soch and Jeff Moser help sort through the noise and highlight the most important things for health systems to know.

Please share your feedback about this episode, or other comments with Trevor and Kelly at [email protected]

The shift to value from fee-for-service in health care was already progressing slowly before COVID-19 overtook the US. In the spring, the pandemic has all but halted elective care, laying bare the vulnerability of a volume-based model, as well as emphasizing the importance of revenue predictability. In this week’s episode, Sg2’s Principal Jim Reilly and Associate Principal Brian Esser discuss the tough decisions health systems must make regarding participation in and preparation for value-based models.

COVID-19 continues its unpredictable surges and declines across the world. In the US, and across the northern hemisphere, a more predictable virus is around the corner in seasonal influenza. While we have never seen seasonal influenza during a global pandemic, symptom overlap and fear of simultaneous infections add significant uncertainty to this flu season. Sg2’s Medicine expert, Justin Cassidy, PhD, walks through potential scenarios for this winter and how health systems can prepare and respond.

We are excited to hear from our listeners so please share any feedback with [email protected]

COVID-19 has revealed critical weaknesses in health system supply chain, which is an area long relegated strictly to hospital operations that could now benefit from strategic scrutiny by other areas of the organization. On this week’s episode of Sg2 Perspectives, Vizient Senior Principal Dr. Blane Schilling and Sg2 Principal Mark Larson change the supply chain discussion to shift away from price and toward value, making a compelling argument for supply chain resiliency as a priority for health system strategy teams.

Health care has long been plagued by challenges with behavioral health issues, and the COVID-19 pandemic has only brought more: an epidemic of mental illness and substance use disorders. This week, Sg2’s behavioral health experts, Principal Jayme Zage and Senior Consultant Stephanie Snider, discuss how health systems can address both new and old challenges through creative care delivery, cost avoidance and a new and improved System of CARE.